SABCS 2015: Symposium Co-director Carlos L. Arteaga Previews Important Advances to be Presented

SABCS logo

Studies presented at this year’s San Antonio Breast Cancer Symposium shed light on new investigational therapies for patients with early-stage disease and advanced disease, offer new information for women hoping to prevent their stage 0 disease from progressing, and evaluate whether less treatment can be more for women with early-stage disease.

Read More

The Cost of Cancer Disparities

Cancer health disparities

The AACR’s disparities conference covered a wide array of issues this year, from the biological factors that make some racial and ethnic groups especially prone to certain types of cancer, to intriguing new ways to improve prevention and detection, to the cost of cancer disparities.

Read More

Q&A With Kimberly Stegmaier, MD, on Pediatric Cancer Research

Kimberly Stegmaier, MD, co-director of the pediatric hematologic malignancy program and associate professor of pediatrics at Dana-Farber Cancer Institute and Boston Children’s Hospital.

Kimberly Stegmaier, MD, co-director of the pediatric hematologic malignancy program and associate professor of pediatrics at Dana-Farber Cancer Institute and Boston Children’s Hospital, previews the areas of research that will be featured at the Advances in Pediatric Cancer Research meeting.

Read More

Q&A With Levi Garraway, MD, PhD, on Hot Topics at the International Conference on Molecular Targets and Cancer Therapeutics

Stethoscope in hand with capsule pill and molecule

Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov. 5-9, provides insights into the meeting.

Read More